Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections (original) (raw)

• Villa E, Fattovich G, Mauro A, Pasino M (2011) Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Dig Liver Dis 43(Suppl 1):S8–S14
  Article PubMed Google Scholar
• Ganem D, Prince AM (2004) Hepatitis B virus infection—natural history and clinical consequences. N Engl J Med 350:1118–1129
  Article CAS PubMed Google Scholar
• Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359:1486–1500
  Article CAS PubMed Google Scholar
• Zhang Z, Zhang JY, Wang LF, Wang FS (2012) Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection. J Gastroenterol Hepatol 27:223–230
  Article PubMed CAS Google Scholar
• Chisari FV, Isogawa M, Wieland SF (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58:258–266
  Article CAS Google Scholar
• Bauer T, Sprinzl M, Protzer U (2011) Immune control of hepatitis B virus. Dig Dis 29:423–433
  PubMed Google Scholar
• Guidotti LG, Chisari FV (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19:65–91
  Article CAS PubMed Google Scholar
• Fisicaro P, Valdatta C, Boni C et al (2009) Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58:974–982
  Article CAS PubMed Google Scholar
• Uprichard SL, Wieland SF, Althage A, Chisari FV (2003) Transcriptional and posttranscriptional control of hepatitis B virus gene expression. Proc Natl Acad Sci U S A 100:1310–1315
  Article PubMed Central CAS PubMed Google Scholar
• Wieland SF, Guidotti LG, Chisari FV (2000) Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 74:4165–4173
  Article PubMed Central CAS PubMed Google Scholar
• He YL, Zhao YR, Zhang SL, Lin SM (2006) Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol 12:4788–4793
  PubMed Central CAS PubMed Google Scholar
• Zhang W, Yue B, Wang GQ, Lu SL (2002) Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis. Hepatobiliary Pancreat Dis Int 1:577–580
  CAS PubMed Google Scholar
• Odeh M, Sabo E, Srugo I, Oliven A (2004) Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int 24:110–116
  Article CAS PubMed Google Scholar
• Xiao P, Chen QF, Yang YL, Guo ZH, Chen H (2006) Serum soluble interleukin-2 receptor levels in patients with chronic hepatitis B virus infection and its relation with anti-HBc. World J Gastroenterol 12:482–484
  PubMed Central CAS PubMed Google Scholar
• Liu M, Miao T, Zhu H et al (2012) IL-2-engineered nano-APC effectively activates viral antigen-mediated T cell responses from chronic hepatitis B virus-infected patients. J Immunol 188:1534–1543
  Article CAS PubMed Google Scholar
• Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV (1997) Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99:3025–3033
  Article PubMed Central CAS PubMed Google Scholar
• le Song H, Binh VQ, Duy DN et al (2003) Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28:93–103
  Article CAS Google Scholar
• Schurich A, Pallett LJ, Lubowiecki M et al (2013) The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 9:e1003208
  Article PubMed Central CAS PubMed Google Scholar
• Dadmanesh M, Ghorban K, Hassanshahi G, Momeni M, Arababadi MK (2014) Current information concerning association of IL-12 and hepatitis B infection. Clin Lab 60:185–191
  CAS PubMed Google Scholar
• He D, Yan G, Wang Y (2012) Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection. Cell Immunol 272:162–165
  Article CAS PubMed Google Scholar
• Jegaskanda S, Ahn SH, Skinner N et al (2014) Down-regulation of IL-18 mediated cell signalling and IFN-gamma expression by the hepatitis B virus e antigen. J Virol 88:10412–10420
  Article PubMed Central CAS PubMed Google Scholar
• Li W, Kubo S, Okuda A et al (2010) Effect of IL-18 on expansion of gammadelta T cells stimulated by zoledronate and IL-2. J Immunother 33:287–296
  Article CAS PubMed Google Scholar
• Hegde S, Chen X, Keaton JM, Reddington F, Besra GS, Gumperz JE (2007) NKT cells direct monocytes into a DC differentiation pathway. J Leukoc Biol 81:1224–1235
  Article CAS PubMed Google Scholar
• Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE (1999) The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 17:701–738
  Article CAS PubMed Google Scholar
• Jiang Y, Ma Z, Xin G et al (2010) Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediat Inflamm 2010:143026
  Google Scholar
• Yao Y, Li J, Lu Z et al (2011) Proteomic analysis of the interleukin-4 (IL-4) response in hepatitis B virus-positive human hepatocelluar carcinoma cell line HepG2.2.15. Electrophoresis 32:2004–2012
  Article CAS PubMed Google Scholar
• Barathan M, Mariappan V, Shankar EM, Abdullah BJ, Goh KL, Vadivelu J (2013) Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Cell Death Dis 4:e697
  Article PubMed Central CAS PubMed Google Scholar
• Missale G, Ferrari C, Fiaccadori F (1995) Cytokine mediators in acute inflammation and chronic course of viral hepatitis. Ann Ital Med Int 10:14–18
  CAS PubMed Google Scholar
• Buke AC, Buke M, Altuglu IE et al (2004) Tumor necrosis factor alpha and interleukin 6 productions in response to platelet-activating factor in chronic hepatitis B virus infection. Med Princ Pract 13:273–276
  Article PubMed Google Scholar
• Park Y, Han KH, Kim HS (2011) Serum cytokine levels in patients with chronic hepatitis B according to lamivudine therapy. J Clin Lab Anal 25:414–421
  Article CAS PubMed Google Scholar
• Karimi-Googheri M, Daneshvar H, Nosratabadi R et al (2014) Important roles played by TGF-beta in hepatitis B infection. J Med Virol 86:102–108
  Article CAS PubMed Google Scholar
• Hong MH, Chou YC, Wu YC et al (2012) Transforming growth factor-beta1 suppresses hepatitis B virus replication by the reduction of hepatocyte nuclear factor-4alpha expression. PLoS One 7:e30360
  Article PubMed Central CAS PubMed Google Scholar
• Park SO, Kumar M, Gupta S (2012) TGF-beta and iron differently alter HBV replication in human hepatocytes through TGF-beta/BMP signaling and cellular microRNA expression. PLoS One 7:e39276
  Article PubMed Central CAS PubMed Google Scholar
• Sun C, Fu B, Gao Y et al (2012) TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog 8:e1002594
  Article PubMed Central CAS PubMed Google Scholar
• Wu JF, Wu TC, Chen CH et al (2010) Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. Gastroenterology 138(165–172):e161–e163
  Google Scholar
• Sabat R, Grutz G, Warszawska K et al (2010) Biology of interleukin-10. Cytokine Growth Factor Rev 21:331–344
  Article CAS PubMed Google Scholar
• Das A, Ellis G, Pallant C et al (2012) IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 189:3925–3935
  Article PubMed Central CAS PubMed Google Scholar
• Fenoglio D, Bernuzzi F, Battaglia F et al (2012) Th17 and regulatory T lymphocytes in primary biliary cirrhosis and systemic sclerosis as models of autoimmune fibrotic diseases. Autoimmun Rev 12:300–304
  Article CAS PubMed Google Scholar
• Wu W, Li J, Chen F, Zhu H, Peng G, Chen Z (2010) Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 25:750–757
  Article CAS PubMed Google Scholar
• Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476
  Article CAS PubMed Google Scholar
• Zhao L, Tang Y, You Z et al (2011) Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression. PLoS One 6:e18909
  Article PubMed Central CAS PubMed Google Scholar
• Du WJ, Zhen JH, Zeng ZQ et al (2013) Expression of interleukin-17 associated with disease progression and liver fibrosis with hepatitis B virus infection: IL-17 in HBV infection. Diagn Pathol 8:40
  Article PubMed Central CAS PubMed Google Scholar
• Huang Z, van Velkinburgh JC, Ni B, Wu Y (2012) Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. Liver Int 32:894–901
  Article CAS PubMed Google Scholar
• Langrish CL, McKenzie BS, Wilson NJ, de Waal MR, Kastelein RA, Cua DJ (2004) IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol Rev 202:96–105
  Article CAS PubMed Google Scholar
• Wang Q, Zhou J, Zhang B et al (2013) Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis. PLoS Pathog 9:e1003410
  Article PubMed Central CAS PubMed Google Scholar
• Liang SC, Tan XY, Luxenberg DP et al (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271–2279
  Article PubMed Central CAS PubMed Google Scholar
• Eyerich S, Eyerich K, Pennino D et al (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119:3573–3585
  PubMed Central CAS PubMed Google Scholar
• Hughes T, Becknell B, McClory S et al (2009) Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood 113:4008–4010
  Article PubMed Central CAS PubMed Google Scholar
• Radaeva S, Sun R, Pan HN, Hong F, Gao B (2004) Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39:1332–1342
  Article CAS PubMed Google Scholar
• Park O, Wang H, Weng H et al (2011) In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression. Hepatology 54:252–261
  Article PubMed Central PubMed CAS Google Scholar
• Zhang Y, Cobleigh MA, Lian JQ et al (2011) A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141:1897–1906
  Article PubMed Central CAS PubMed Google Scholar
• Monteleone G, Pallone F, Macdonald TT (2009) Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease. Cytokine Growth Factor Rev 20:185–191
  Article CAS PubMed Google Scholar
• Spolski R, Leonard WJ (2008) The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 20:295–301
  Article PubMed Central CAS PubMed Google Scholar
• Spolski R, Leonard WJ (2010) IL-21 and T follicular helper cells. Int Immunol 22:7–12
  Article PubMed Central CAS PubMed Google Scholar
• Publicover J, Goodsell A, Nishimura S et al (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121:1154–1162
  Article PubMed Central CAS PubMed Google Scholar
• Franks I (2011) Viral hepatitis: interleukin 21 has a key role in age-dependent response to HBV. Nat Rev Gastroenterol Hepatol 8:243
  Google Scholar
• Tuncbilek S (2014) Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection. World J Gastroenterol 20:6226–6235
  Article PubMed Central PubMed CAS Google Scholar
• Sodsai P, Surakiatchanukul T, Kupatawintu P, Tangkitvanich P, Hirankarn N (2013) Association of cytokine and cytokine receptor gene polymorphisms with the risk of chronic hepatitis B. Asian Pac J Allergy Immunol 31:277–285
  Article CAS PubMed Google Scholar
• Lian JQ, Yang XF, Zhao RR et al (2014) Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection. Hepat Mon 14:e18892
  PubMed Central PubMed Google Scholar
• Abbas Z, Siddiqui AR (2011) Management of hepatitis B in developing countries. World J Hepatol 3:292–299
  Article PubMed Central PubMed Google Scholar
• Liver EAFTSOT (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167–185
  Article Google Scholar
• Arababadi MK, Pourfathollah AA, Jafarzadeh A, Hassanshahi G (2010) Serum levels of IL-10 and IL-17A in occult HBV-infected South-East Iranian patients. Hepat Mon 10:31–35
  PubMed Central PubMed Google Scholar
• Zhang JY, Zhang Z, Lin F et al (2010) Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51:81–91
  Article CAS PubMed Google Scholar
• He D, Li M, Guo S et al (2013) Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels. J Clin Immunol 33:1240–1249
  Article PubMed Central CAS PubMed Google Scholar
• Bertolino P, McCaughan GW, Bowen DG (2002) Role of primary intrahepatic T-cell activation in the ‘liver tolerance effect’. Immunol Cell Biol 80:84–92
  Article PubMed Google Scholar
• Dumortier J, Schonig K, Oberwinkler H et al (2005) Liver-specific expression of interferon gamma following adenoviral gene transfer controls hepatitis B virus replication in mice. Gene Ther 12:668–677
  Article CAS PubMed Google Scholar
• Isogawa M, Robek MD, Furuichi Y, Chisari FV (2005) Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79:7269–7272
  Article PubMed Central CAS PubMed Google Scholar
• Chokshi S, Cooksley H, Riva A et al (2014) Identification of serum cytokine profiles associated with HBeAg seroconversion following antiviral treatment interruption. Viral Immunol 27:235–244
  Article CAS PubMed Google Scholar
• Zhang G, Li Z, Han Q et al (2011) Altered TNF-alpha and IFN-gamma levels associated with PD1 but not TNFA polymorphisms in patients with chronic HBV infection. Infect Genet Evol 11:1624–1630
  Article CAS PubMed Google Scholar
• Wang B, Wang J, Zheng Y et al (2010) A study of TNF-alpha-238 and −308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology 42:674–680
  Article CAS PubMed Google Scholar
• Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B (2008) Association of TNF-alpha −308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol 8:20–25
  Article CAS PubMed Google Scholar
• Fletcher GJ, Samuel P, Christdas J et al (2011) Association of HLA and TNF polymorphisms with the outcome of HBV infection in the South Indian population. Genes Immun 12:552–558
  Article CAS PubMed Google Scholar
• Toe JG, Pellegrini M, Mak TW (2013) Promoting immunity during chronic infection—the therapeutic potential of common gamma-chain cytokines. Mol Immunol 56:38–47
  Article CAS PubMed Google Scholar
• Zeuzem S, Carreno V (2001) Interleukin-12 in the treatment of chronic hepatitis B and C. Antivir Res 52:181–188
  Article CAS PubMed Google Scholar
• Tung NH, Quang TH, Son JH et al (2011) Inhibitory effect of ginsenosides from steamed ginseng-leaves and flowers on the LPS-stimulated IL-12 production in bone marrow-derived dendritic cells. Arch Pharm Res 34:681–685
  Article PubMed CAS Google Scholar
• Gao QJ, Liu DW, Zhang SY et al (2009) Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 15:5610–5619
  Article PubMed Central CAS PubMed Google Scholar
• Dong Y, Xi H, Yu Y, Wang Q, Jiang K, Li L (2002) Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: a study on the anti-hepatitis B virus mechanism of oxymatrine. J Gastroenterol Hepatol 17:1299–1306
  Article CAS PubMed Google Scholar
• Gur A, Dikici B, Nas K, Bosnak M, Haspolat K, Sarac AJ (2005) Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis? BMC Gastroenterol 5:30
  Article PubMed Central PubMed CAS Google Scholar
• Kao JT, Lai HC, Tsai SM et al (2012) Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naive hepatitis B infection patients. Liver Int 32:928–936
  Article CAS PubMed Google Scholar
• Pillai MR, Collison LW, Wang X et al (2011) The plasticity of regulatory T cell function. J Immunol 187:4987–4997
  Article PubMed Central CAS PubMed Google Scholar
• Aalaei-Andabili SH, Alavian SM (2012) Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine 30:5595–5602
  Article CAS PubMed Google Scholar
• Xu D, Fu J, Jin L et al (2006) Circulating and liver resident CD4+ CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B. J Immunol 177:739–747
  Article CAS PubMed Google Scholar
• Liu F, Tong F, He Y, Liu H (2011) Detectable expression of IL-35 in CD4+ T cells from peripheral blood of chronic hepatitis B patients. Clin Immunol 139:1–5
  Article CAS PubMed Google Scholar
• Zhang KQ, Polga D, Salzman SA, Burmester JK (2002) Amino acids 67 and 68 of transforming growth factor-beta regulate binding to a glycosyl phosphatidyl inositol-linked membrane protein on vascular endothelial cells. Cytokines Cell Mol Ther 7:25–30
  Article CAS PubMed Google Scholar
• Besnard AG, Sabat R, Dumoutier L et al (2011) Dual Role of IL-22 in allergic airway inflammation and its cross-talk with IL-17A. Am J Respir Crit Care Med 183:1153–1163
  Article CAS PubMed Google Scholar
• Chen Y, Xie X, Gu L, Huang XH, Peng XM (2013) Furin mRNA expression in peripheral blood correlates with chronic hepatitis B virus infection. Hepatol Res 43:208–216
  Article CAS PubMed Google Scholar
• Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2095
  Article CAS PubMed Google Scholar
• Ejrnaes M, Filippi CM, Martinic MM et al (2006) Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med 203:2461–2472
  Article PubMed Central CAS PubMed Google Scholar
• Wang B, Zhao XP, Fan YC, Zhang JJ, Zhao J, Wang K (2013) IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line. Antiviral Res 97:285–292
  Article CAS PubMed Google Scholar
• Oppmann B, Lesley R, Blom B et al (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725
  Article CAS PubMed Google Scholar
• Xie MH, Aggarwal S, Ho WH et al (2000) Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R. J Biol Chem 275:31335–31339
  Article CAS PubMed Google Scholar
• Kotenko SV, Izotova LS, Mirochnitchenko OV et al (2001) Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes. J Biol Chem 276:2725–2732
  Article CAS PubMed Google Scholar
• Brand S, Dambacher J, Beigel F et al (2007) IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro. Am J Physiol Gastrointest Liver Physiol 292:G1019–G1028
  Article CAS PubMed Google Scholar
• Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA (2007) Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27:647–659
  Article PubMed Central CAS PubMed Google Scholar
• Kakimi K, Lane TE, Wieland S et al (2001) Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194:1755–1766
  Article PubMed Central CAS PubMed Google Scholar
• Xiang X, Gui H, King NJ et al (2012) IL-22 and non-ELR-CXC chemokine expression in chronic hepatitis B virus-infected liver. Immunol Cell Biol 90:611–619
  Article CAS PubMed Google Scholar
• Zeng R, Spolski R, Casas E, Zhu W, Levy DE, Leonard WJ (2007) The molecular basis of IL-21-mediated proliferation. Blood 109:4135–4142
  Article PubMed Central CAS PubMed Google Scholar
• Spolski R, Leonard WJ (2008) Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 26:57–79
  Article CAS PubMed Google Scholar
• Ettinger R, Kuchen S, Lipsky PE (2008) The role of IL-21 in regulating B-cell function in health and disease. Immunol Rev 223:60–86
  Article CAS PubMed Google Scholar
• Iannello A, Tremblay C, Routy JP, Boulassel MR, Toma E, Ahmad A (2008) Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts. Viral Immunol 21:385–388
  Article CAS PubMed Google Scholar
• Hu X, Ma S, Huang X et al (2011) Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat 18:458–467
  Article CAS PubMed Google Scholar
• Kwon H, Lok AS (2011) Hepatitis B therapy. Nat Rev Gastroenterol Hepatol 8:275–284
  CAS PubMed Google Scholar
• Tseng TC, Kao JH, Chen DS (2014) Peginterferon alpha in the treatment of chronic hepatitis B. Expert Opin Biol Ther 14:995–1006
  Article CAS PubMed Google Scholar
• Liu YZ, Hou FQ, Ding P, Ren YY, Li SH, Wang GQ (2012) Pegylated interferon alpha enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients. Virol J 9:274
  Article PubMed Central PubMed CAS Google Scholar
• Belloni L, Allweiss L, Guerrieri F et al (2012) IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122:529–537
  Article PubMed Central CAS PubMed Google Scholar
• Xu C, Guo H, Pan XB et al (2010) Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus. J Virol 84:9332–9340
  Article PubMed Central CAS PubMed Google Scholar
• Brunetto MR, Oliveri F, Colombatto P, Coco B, Ciccorossi P, Bonino F (2003) Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon. J Hepatol 39(Suppl 1):S164–S167
  Article CAS PubMed Google Scholar
• Rigopoulou EI, Suri D, Chokshi S et al (2005) Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42:1028–1036
  Article CAS PubMed Google Scholar
• Szkaradkiewicz A, Jopek A, Wysocki J (2005) Effects of IL-12 and IL-18 on HBcAg-specific cytokine production by CD4 T lymphocytes of children with chronic hepatitis B infection. Antiviral Res 66:23–27
  Article CAS PubMed Google Scholar
• Grimm D, Heeg M, Thimme R (2013) Hepatitis B virus: from immunobiology to immunotherapy. Clin Sci (Lond) 124:77–85
  Article CAS Google Scholar
• Ghany MG, Doo EC (2009) Antiviral resistance and hepatitis B therapy. Hepatology 49:S174–S184
  Article PubMed Central CAS PubMed Google Scholar
• Nebbia G, Peppa D, Maini MK (2012) Hepatitis B infection: current concepts and future challenges. QJM 105:109–113
  Article PubMed Central CAS PubMed Google Scholar
• Ahlenstiel G, Edlich B, Hogdal LJ et al (2011) Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 141:1231–1239, 1239 e1231-1232
  Article PubMed Central CAS PubMed Google Scholar
• Craxi A, Di Bona D, Camma C (2003) Interferon-alpha for HBeAg-positive chronic hepatitis B. J Hepatol 39(Suppl 1):S99–S105
  Article CAS PubMed Google Scholar
• Shi B, Ren G, Hu Y, Wang S, Zhang Z, Yuan Z (2012) HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes. PLoS One 7:e44900
  Article PubMed Central CAS PubMed Google Scholar
• Walsh R, Locarnini S (2012) Hepatitis B precore protein: pathogenic potential and therapeutic promise. Yonsei Med J 53:875–885
  Article PubMed Central CAS PubMed Google Scholar
• Reijnders JG, Perquin MJ, Zhang N, Hansen BE, Janssen HL (2010) Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B. Gastroenterology 139:491–498
  Article CAS PubMed Google Scholar
• Buster EH, Hansen BE, Lau GK et al (2009) Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology 137:2002–2009
  Article CAS PubMed Google Scholar
• Janssen HL, van Zonneveld M, Senturk H et al (2005) Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365:123–129
  Article CAS PubMed Google Scholar
• Lau GK, Piratvisuth T, Luo KX et al (2005) Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B. N Engl J Med 352:2682–2695
  Article CAS PubMed Google Scholar
• Piccolo P, Lenci I, Demelia L et al (2009) A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B. Antivir Ther 14:1165–1174
  Article CAS PubMed Google Scholar
• Takkenberg B, Terpstra V, Zaaijer H et al (2011) Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir. J Gastroenterol Hepatol 26:1527–1535
  Article CAS PubMed Google Scholar
• Scott DL, Wolfe F, Huizinga TW (2010) Rheumatoid arthritis. Lancet 376:1094–1108
  Article PubMed Google Scholar
• Rutgeerts P, Vermeire S, Van Assche G (2009) Biological therapies for inflammatory bowel diseases. Gastroenterology 136:1182–1197
  Article CAS PubMed Google Scholar
• Ostuni P, Botsios C, Punzi L, Sfriso P, Todesco S (2003) Hepatitis B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 62:686–687
  Article PubMed Central CAS PubMed Google Scholar
• Chevaux JB, Nani A, Oussalah A et al (2010) Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis 16:916–924
  Article PubMed Google Scholar
• Robinson H, Walker-Bone K (2009) Anti-TNF-alpha therapy for rheumatoid arthritis among patients with chronic hepatitis B infection. Rheumatology (Oxford) 48:448–450
  Article CAS Google Scholar
• Ryu HH, Lee EY, Shin K et al (2012) Hepatitis B virus reactivation in rheumatoid arthritis and ankylosing spondylitis patients treated with anti-TNFalpha agents: a retrospective analysis of 49 cases. Clin Rheumatol 31:931–936
  Article PubMed Google Scholar
• Lee YH, Bae SC, Song GG (2013) Hepatitis B virus reactivation in HBsAg-positive patients with rheumatic diseases undergoing anti-tumor necrosis factor therapy or DMARDs. Int J Rheum Dis 16:527–531
  Article CAS PubMed Google Scholar
• Vassilopoulos D (2011) Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? Yes. Eur J Intern Med 22:572–575
  Article PubMed Google Scholar
• Nosotti L, Francesconi F, Izzi S, Berardesca E, Morrone A, Bonifati C (2010) Safety of antitumour necrosis factor-alpha therapy in psoriatic patients with hepatitis B virus infection. Br J Dermatol 162:1408–1410
  Article CAS PubMed Google Scholar
• Arababadi MK, Pourfathollah AA, Jafarzadeh A et al (2011) Non-association of IL-12 +1188 and IFN-gamma +874 polymorphisms with cytokines serum level in occult HBV infected patients. Saudi J Gastroenterol 17:30–35
  Article PubMed Central PubMed Google Scholar
• Pramoolsinsup C (2002) Management of viral hepatitis B. J Gastroenterol Hepatol 17(Suppl):S125–S145
  Article PubMed Google Scholar
• Carreno V, Zeuzem S, Hopf U et al (2000) A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B. J Hepatol 32:317–324
  Article CAS PubMed Google Scholar
• Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929–979
  Article CAS PubMed Google Scholar
• Goddard S, Youster J, Morgan E, Adams DH (2004) Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am J Pathol 164:511–519
  Article PubMed Central CAS PubMed Google Scholar
• Tjwa ET, van Oord GW, Hegmans JP, Janssen HL, Woltman AM (2011) Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 54:209–218
  Article CAS PubMed Google Scholar
• Chou YC, Chen ML, Hu CP et al (2007) Transforming growth factor-beta1 suppresses hepatitis B virus replication primarily through transcriptional inhibition of pregenomic RNA. Hepatology 46:672–681
  Article CAS PubMed Google Scholar
• Tarr PE, Lin R, Mueller EA, Kovarik JM, Guillaume M, Jones TC (1996) Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine. Vaccine 14:1199–1204
  Article CAS PubMed Google Scholar
• Martin J, Bosch O, Moraleda G, Bartolome J, Quiroga JA, Carreno V (1993) Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B. Hepatology 18:775–780
  Article CAS PubMed Google Scholar
• Wang J, Zhu Q, Zhang T, Yu H (2002) A pilot study on the combined therapy of granulocyte-macrophage colony-stimulating factor and hepatitis B vaccine on chronic hepatitis B virus carrier children. Chin Med J (Engl) 115:1824–1828
  CAS Google Scholar
• Qing Y, Chen M, Zhao J et al (2010) Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice. Vaccine 28:4301–4307
  Article CAS PubMed Google Scholar
• Overton ET, Sungkanuparph S, Klebert M et al (2011) GM-CSF fails to improve immune responses to booster hepatitis B vaccination in HIV-infected individuals. Open Virol J 5:109–113
  Article PubMed Central CAS PubMed Google Scholar
• Yuan Q, Li PD, Li BH et al (2009) Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells. J Cancer Res Clin Oncol 135:131–140
  Article CAS PubMed Google Scholar
• Corry DB, Kheradmand F (2002) Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 1:185–193
  Article CAS PubMed Google Scholar
• Fan Z, Spencer JA, Lu Y et al (2010) In vivo tracking of ‘color-coded’ effector, natural and induced regulatory T cells in the allograft response. Nat Med 16:718–722
  Article PubMed Central CAS PubMed Google Scholar
• Meyers JA, Liu AY, McTiernan A et al (2008) Serum leptin concentrations and markers of immune function in overweight or obese postmenopausal women. J Endocrinol 199:51–60
  Article CAS PubMed Google Scholar
• Gorski KS, Waller EL, Bjornton-Severson J et al (2006) Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol 18:1115–1126
  Article CAS PubMed Google Scholar
• Wilson MT, Johansson C, Olivares-Villagomez D et al (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 100:10913–10918
  Article PubMed Central CAS PubMed Google Scholar
• Comella K, Nakamura M, Melnik K et al (2001) Effects of antibody concentration on the separation of human natural killer cells in a commercial immunomagnetic separation system. Cytometry 45:285–293
  Article CAS PubMed Google Scholar
• Matsuda JL, Naidenko OV, Gapin L et al (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192:741–754
  Article PubMed Central CAS PubMed Google Scholar
• Wynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4:583–594
  Article PubMed Central CAS PubMed Google Scholar
• Meier R, Golovko D, Tavri S et al (2011) Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging. Magn Reson Med 65:756–763
  Article CAS PubMed Google Scholar